XML 105 R91.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Acquisition-Related Amortization and Remeasurement - Additional Information (Details) - License Agreement [Member] - USD ($) $ in Millions |  | 1 Months Ended |  |
--- | --- | --- | --- | ---
Dec. 29, 2022 | May 31, 2022 | Apr. 30, 2021 | Dec. 31, 2023 | Dec. 31, 2022
Research And Development Arrangement Contract To Perform For Others [Line Items] |  |  |  |  |
Consideration agreed to pay with additional payments contingent upon reaching future commercialization and revenue-based milestones | $ 0.2 |  |  |  |
Initial payment accrued |  |  |  |  | $ 0.2
Contingent Payment Upon Reaching FDA Milestone |  |  | $ 4.0 |  |
Amount Received for the year |  | $ 1.5 | $ 0.5 |  |
Contingent consideration milestone obligation |  | $ 3.5 |  |  |
Other Current Liabilities [Member] |  |  |  |  |
Research And Development Arrangement Contract To Perform For Others [Line Items] |  |  |  |  |
Contingent consideration accrued |  |  |  | $ 1.0 | $ 1.0

X
- Definition Amount received for the year. + References No definition available. + Details
Name: | ofix_AmountReceivedForYear
Namespace Prefix: | ofix_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Consideration agreed to pay with additional payments contingent upon reaching future commercialization and revenue-based milestones. + References No definition available. + Details
Name: | ofix_ConsiderationAgreedToPayWithAdditionalPaymentsContingentUponReachingFutureCommercializationAndRevenueBasedMilestones
Namespace Prefix: | ofix_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Contingent consideration accrued. + References No definition available. + Details
Name: | ofix_ContingentConsiderationAccrued
Namespace Prefix: | ofix_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Contingent consideration milestone obligation. + References No definition available. + Details
Name: | ofix_ContingentConsiderationMilestoneObligation
Namespace Prefix: | ofix_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Contingent payment upon reaching fda milestone. + References No definition available. + Details
Name: | ofix_ContingentPaymentUponReachingFDAMilestone
Namespace Prefix: | ofix_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Initial payment accrued. + References No definition available. + Details
Name: | ofix_InitialPaymentAccrued
Namespace Prefix: | ofix_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 730 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483041/730-20-50-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 730 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483041/730-20-50-1 + Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_LicenseAgreementTermsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |